Jane Street’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-84
| Closed | -$1.67K | – | 9792 |
|
|
2023
Q3 | $1.67K | Buy |
+84
| New | +$3.62K | ﹤0.01% | 8491 |
|
|
2023
Q1 | – | Sell |
-941
| Closed | -$89.6K | – | 9913 |
|
|
2022
Q4 | $91.7K | Buy |
+941
| New | +$136K | ﹤0.01% | 8143 |
|
|
2022
Q3 | – | Sell |
-744
| Closed | -$216K | – | 10455 |
|
|
2022
Q2 | $138K | Buy |
744
+553
| +290% | +$52.8K | ﹤0.01% | 8468 |
|
|
2022
Q1 | $19K | Sell |
191
-150
| -44% | -$19.3K | ﹤0.01% | 9954 |
|
|
2021
Q4 | $56K | Buy |
341
+274
| +409% | +$60.2K | ﹤0.01% | 9493 |
|
|
2021
Q3 | $19K | Sell |
67
-584
| -90% | -$179K | ﹤0.01% | 9750 |
|
|
2021
Q2 | $258K | Buy |
651
+287
| +79% | +$134K | ﹤0.01% | 8412 |
|
|
2021
Q1 | $196K | Buy |
364
+128
| +54% | +$79.7K | ﹤0.01% | 8287 |
|
|
2020
Q4 | $89K | Sell |
236
-593
| -72% | -$236K | ﹤0.01% | 7232 |
|
|
2020
Q3 | $314K | Buy |
829
+50
| +6% | +$22.1K | ﹤0.01% | 5815 |
|
|
2020
Q2 | $383K | Buy |
779
+658
| +544% | +$293K | ﹤0.01% | 5475 |
|
|
2020
Q1 | $44K | Buy |
121
+19
| +19% | +$9.83K | ﹤0.01% | 5106 |
|
|
2019
Q4 | $72K | Sell |
102
-175
| -63% | -$120K | ﹤0.01% | 4878 |
|
|
2019
Q3 | $177K | Buy |
+277
| New | +$220K | ﹤0.01% | 4680 |
|
|
2019
Q1 | – | Sell |
-741
| Closed | -$208K | – | 5630 |
|
|
2018
Q4 | $208K | Buy |
741
+406
| +121% | +$161K | ﹤0.01% | 4449 |
|
|
2018
Q3 | $161K | Buy |
+335
| New | +$144K | ﹤0.01% | 4762 |
|
|
2018
Q1 | – | Sell |
-71
| Closed | -$44.2K | – | 5380 |
|
|
2017
Q4 | $44K | Sell |
71
-116
| -62% | -$83.3K | ﹤0.01% | 4434 |
|
|
2017
Q3 | $173K | Buy |
+187
| New | +$166K | ﹤0.01% | 4167 |
|
|
2017
Q2 | – | Sell |
-458
| Closed | -$449K | – | 4852 |
|
|
2017
Q1 | $436K | Buy |
+458
| New | +$426K | ﹤0.01% | 3016 |
|
|
2016
Q4 | – | Sell |
-144
| Closed | -$130K | – | 4606 |
|
|
2016
Q3 | $121K | Sell |
144
-131
| -48% | -$105K | ﹤0.01% | 3824 |
|
|
2016
Q2 | $226K | Sell |
275
-164
| -37% | -$179K | ﹤0.01% | 3620 |
|
|
2016
Q1 | $489K | Buy |
439
+279
| +174% | +$286K | ﹤0.01% | 2628 |
|
|
2015
Q4 | $200K | Sell |
160
-633
| -80% | -$1.05M | ﹤0.01% | 3605 |
|
|
2015
Q3 | $1.07M | Sell |
793
-49
| -6% | -$80.9K | 0.01% | 1575 |
|
|
2015
Q2 | $1.51M | Buy |
842
+293
| +53% | +$455K | 0.01% | 1193 |
|
|
2015
Q1 | $887K | Buy |
+549
| New | +$814K | 0.01% | 1474 |
|
|
2014
Q4 | – | Sell |
-109
| Closed | -$43K | – | 3019 |
|
|
2014
Q3 | $43K | Buy |
109
+25
| +30% | +$12.1K | ﹤0.01% | 2431 |
|
|
2014
Q2 | $51K | Buy |
+84
| New | +$46.8K | ﹤0.01% | 2424 |
|
|
2013
Q4 | – | Sell |
-344
| Closed | -$203K | – | 2879 |
|
|
2013
Q3 | $203K | Sell |
344
-534
| -61% | -$241K | ﹤0.01% | 2403 |
|
|
2013
Q2 | $278K | Buy |
+878
| New | +$244K | ﹤0.01% | 1962 |
|
Other funds holding TCRT
MP
DCM
MCA
Jane Street's TCRT Position: Q4 2023 in Review
Jane Street sold out of Alaunos Therapeutics (TCRT) in Q4 2023, closing a stake of 84 shares — an estimated $1.67K sold.
Jane Street first reported a position in TCRT in Q2 2013 and held it in 30 quarters. The position peaked at $1.51M in Q2 2015. 82 funds tracked by Wall St. Rank hold TCRT as of Q4 2023.
- Jane Street reported no remaining Alaunos Therapeutics position as of Q4 2023 after selling out during the quarter.
- Jane Street sold 84 Alaunos Therapeutics shares in Q4 2023, an estimated $1.67K.
- Jane Street first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 30 quarters.
- Jane Street's Alaunos Therapeutics position peaked at $1.51M in Q2 2015.
- 82 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2023.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.